|
|
The influence of Trimetazadine on the clinical efficacy of patients with chronic heart failure |
ZHANG Bo |
The First Department of Internal Medicine,Traditional Chinese Medicine Hospital of Meizhou City in Guangdong Province,Meizhou 514071,China |
|
|
Abstract ObjectiveTo evaluate the effects of Trimetazadine on patients with chronic heart failure.Methods100 patients with chronic heart failure treated in our hospital form February 2016 to February 2017 were selected as the subjects,and divided into therapy group and control group,50 cases in each group.The control group patients were given basic treatment with angiotensin converting enzyme inhibitor(ACEI),digitalis,diuretics,βblock.And the therapy group were given Trimetazadine in addition to the basic treatment.Heart function,LVEF,LVDD,LVDS and BNP level in those patients were observed before and after three months treatment.ResultsCompared with the control group,the total effective rate increased significantly in the therapy group.After treatment,the LVEF of the patients was obviously improved,and RHR in therapy group was decreased.LVDD,LVDS and BNP level also decreased at 3 months compared with those in therapy group,the difference was statistically significant(P<0.05).ConclusionIn additional to the conventional therapy,Trimetazadine can improve the left ventricular performance and remodeling in patients with coronary heart failure.
|
|
|
|
|
[1] |
Dalla-voltaS,Maraglino G,Della-valentina P,et al.Comparison of trimetazidine with nifedipine in effort angina:a doubleblind,crossover study[J].Cardiovasc Drugs Ther,1990,4(4):853-859.
|
[2] |
孔倩文.曲美他嗪对心力衰竭心功能分级及左室射血分数的影响[J].中国医药导报,2016,13(26):148-151.
|
[3] |
杨英珍.全国心肌炎心肌病专研讨会纪要[J].临床心血管病杂志,1995,11(6):324-326.
|
[4] |
Zhang L,Lu Y,Jiang H,et al.Additional use of trimetazidine in patients with chronic heart failure:a meta-analysis[J].J Am Coll Cardiol,2012,59(10):913-922.
|
[5] |
许玲,赵国安.曲美他嗪对慢性心力衰竭患者心功能及血清相关因子的影响[J].中国现代药物应用,2015,9(3):76-77.
|
[6] |
刘立新,毕磊,崔振双,等.曲美他嗪联合辅酶Q10治疗高龄慢性心力衰竭患者的效果观察[J].中国综合临床,2016,32(3):224-227.
|
[7] |
Zhao P,Zhang J,Yin XG,et al.The effect of trimetazidine on cardiac function in diabetic patients with idiopathic dilated cardiomyopathy[J].Life Sci,2013,92(11):633-8.
|
[8] |
Napoli PD,Taccardi AA,Barsotti A.Long term cardioprotective action of trimetazidine and potential effect on the inflammatory process in patients with ischaemic dilated cardiomyopathy[J].Heart,2005,91(2):161-5.
|
[9] |
黄国鹏,李洪林,宋文信.曲美他嗪对慢性心力衰竭患者心率变异性的影响[J].重庆医学,2011,40(30):3101-3103.
|
[10] |
钟文娟,陈慧,吴小盈.检测氨基末端脑钠肽前体对心力衰竭患者的预后价值[J].中华高血压杂志,2010,18(1):41.
|
[11] |
李志强.贝那普利联合美托洛尔治疗慢性心力衰竭患者的临床疗效分析[J].实用临床医药杂志,2013,17(7):79-81.
|
[15] |
衣绍蕊,孙经武,张明哲,等.曲美他嗪对慢性心力衰竭患者血管内皮功能的影响研究[J].中国全科医学,2014,17(20):2321-2324.
|
[12] |
Zhang L,Lu Y,Jiang H,et al.Additional use of trimetazidine in patients with chronic heart failure:a Meta-analysis[J].Cardiology,2012,59(10):913-922.
|
[13] |
Grajek S,Michalak M.The effect of trimetazidine added to pharmacologicaltreatmenton all-cause mortality in patients with systolic heart failure[J].Cardiology,2015,131(1):22-9.
|
[14] |
Burnett JC Jr.Coronary endothelial dysfunction in the hypertensivepatient:frommyocardialischemiatoheartfailure[J].J Hum Hypertens,1997,11(1):45.
|
|
|
|